EL NUEVO ALGORITMO AFIB INTELLISENSE DETECTA UNA POSIBLE FIBRILACIÓN AURICULAR EN CADA CONTROL DE PRESIÓN, MEJORANDO LA DETECCIÓN TEMPRANA Y LA POSIBLE PREVENCIÓN DE COMPLICACIONES GRAVES (NOTICIA EN BREVE) OMRON Healthcare ha lanzado nuevos tensiómetros equipados con tecnología de detección … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, Healthcare, News, Pharma & Biotech, Spain, Technology
Tagged accidente cerebrovascular, accidente cerebrovascular cardioembólico, AFib Intellisense, algoritmo de Intellisense AFib, aprendizaje automático, autocontrol, Ayumu Okada, cardíacas, cardiopatías, cero cardiovasculares, cero enfermedades cerebrovasculares, control de la salud, control domiciliario de la salud, detección de fibrilación auricular, ESC2024, FA, fibrilación auricular, hipertensión, HRS2024, IA, Inteligencia artificial, Intellisense AFib, interrupciones en el pulso específicas de la FA, la gestión de afecciones cardiovasculares, la monitorización remota de pacientes, la Sra. Lucia Prada, latido irregular, los cuidados respiratorios, los dispositivos de terapia del dolor, M6 Comfort AFib, M7 Intelli IT AFib, OMRON, OMRON Healthcare, ritmo cardíaco irregular, tecnología médica, tensiómetros, tension, X7 smart AFib
(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, and COVID-19. The company revealed promising data across its portfolio, including Beyfortus, an antibody … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Beyfortus, COVID-19, FluMist, hMPV, IDWeek 2024, Iskra Reic, IVX-A12, Respiratory Disease Prevention, RSV, safety, Vaccine Innovation
(IN BRIEF) Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnerable communities in the Americas. Boehringer Ingelheim pledged $5 million to support WHO’s 2025–2028 General Program of Work … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Society
Tagged Anil Soni, Boehringer Ingelheim, Global Healthcare Access, Médard Schoenmaeckers, mental health, partnership, society, Suicide Prevention Efforts, WHO Foundation
(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Akagera Medicines, Belen Calvo Uyarra, Ebola, EIB Global, HIV, investment, Lassa fever, Michael Fairbanks, partnership, Regis Rugemanshuro, Rwanda, sustainability, Thomas Östros, tuberculosis, vaccine, wellness
(IN BRIEF) The University of Liverpool has signed a Memorandum of Understanding (MoU) with Roche Diagnostics UK and Ireland to enhance research and innovation focused on improving health outcomes and addressing health inequalities. This partnership aims to align with Roche’s … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged health innovation, Healthcare, inequalities, partnership, Professor Sarah Coupland, Professor Tim Jones, Roche, sustainability, University of Liverpool, wellness
(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated a significant reduction in nasal polyp size and nasal obstruction after … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged chronic rhinosinusitis, Depemokimab, GSK, Kaivan Khavandi, Nasal Polyps, safety
(IN BRIEF) Roche has announced positive two-year data from its RAINBOWFISH study, showcasing the effectiveness of Evrysdi® (risdiplam) in treating children with spinal muscular atrophy (SMA) when administered before symptoms appear. The study revealed that most children achieved key motor … Read the full press release
(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China for the treatment of patients with unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) with HER2 (ERBB2) mutations who have previously undergone systemic … Read the full press release
(IN BRIEF) Merck has officially opened a new €290 million biosafety testing facility in Rockville, Maryland, designed to meet the increasing global demand for biosafety testing services. This state-of-the-art facility consolidates various operations, including biosafety testing, analytical development, and cell … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Accelerate Testing Timelines, Benjamin Hein, Biosafety Testing Facility, Drug Safety, Merck, partnership, Rockville, sustainability, USA
(IN BRIEF) Roche has announced the CE certification of its VENTANA CLDN18 (43-14A) RxDx Assay, marking a significant advancement in companion diagnostics for patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma. This diagnostic tool enables clinicians to identify patients who … Read the full press release
(IN BRIEF) FinVector, a leading biopharmaceutical company, has inaugurated a cutting-edge production facility in Kuopio, Finland, aimed at manufacturing gene therapy products. The new Finport facility, which is set to become one of the world’s largest for such therapies, represents … Read the full press release
Posted in Banks, Business, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged cancer treatment, FinVector, Gene Therapy Facility, Jean-Frédéric Paulsen, KUOPIO, NIB, partnership, Petri Peltonen, Professor Seppo Ylä-Herttuala, Soile Lahti, sustainability
(IN BRIEF) Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children in underserved urban communities across six cities worldwide. Backed by an investment of over 250 million Danish kroner and a coalition … Read the full press release
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Brazil, CANADA, France, Global Childhood Obesity Initiative, Healthier Urban Communities, Japan, Katrine DiBona, Novo Nordisk, partnership, South Africa, Spain, sustainability, wellbeing
(IN BRIEF) QIAGEN Digital Insights has announced an expanded partnership with Neo4j, aiming to enhance biomedical data analysis for the biopharmaceutical industry. This collaboration will integrate Neo4j’s graph database and machine learning capabilities with QIAGEN’s extensive biomedical knowledge base. By … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Biomedical Data Analysis, Biopharma Industry, Dominic John, Neo4j, partnership, QIAGEN, Sudhir Hasbe, sustainability, USA
(IN BRIEF) Fabentech, a French biopharmaceutical company, has secured a €20 million loan from the European Investment Bank (EIB) through the HERA Invest initiative. The funding will support Fabentech’s research, bioproduction, and expansion of its FabShield® technology, which focuses on … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Biological Threat Response, EIB, Fabentech, France, Healthcare, Hera, Laurent Muschel, Pandemic Preparedness, partnership, Sébastien Iva, sustainability
(IN BRIEF) AstraZeneca’s inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk of severe asthma exacerbations in patients with intermittent or mild persistent asthma, according to high-level results from the BATURA Phase IIIb trial. The trial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Airsupra, AstraZeneca, Professor James Donohue, safety, Severe Asthma, Sharon Barr
(IN BRIEF) AstraZeneca and Daiichi Sankyo announced that their drug Enhertu (trastuzumab deruxtecan) has been granted Priority Review by the US FDA for treating patients with unresectable or metastatic HER2-low or HER2-ultralow breast cancer who have previously undergone endocrine therapy. … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, Breast Cancer Patients, Daiichi Sankyo, HER2-Low, Ken Takeshita, partnership, Pre-Chemotherapy, safety, Susan Galbraith, sustainability, Ultralow
(IN BRIEF) Fresenius Kabi, in collaboration with Formycon, has received approval from the European Commission (EC) for FYB202, a biosimilar of ustekinumab (marketed as Stelara® by Johnson & Johnson). This biosimilar is approved for the treatment of serious inflammatory diseases. … Read the full press release
Posted in Business, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Formycon, Fresenius Kabi, FYB202, partnership, safety, Stelara®, sustainability, Ustekinumab Biosimilar
(IN BRIEF) Fresenius Kabi, in partnership with Formycon AG, has received European Commission approval for Otulfi®, a biosimilar of ustekinumab. This new product, authorized for both subcutaneous and intravenous formulations, will treat inflammatory conditions such as Crohn’s disease, plaque psoriasis, … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Dr. Sang-Jin Pak, Formycon AG, Fresenius Kabi, inflammatory diseases, Otulfi®, partnership, safety, sustainability, Ustekinumab Biosimilar
(IN BRIEF) SCHOTT Pharma, Gerresheimer, and Stevanato Group have formed the “Alliance for RTU” to promote the adoption of ready-to-use (RTU) vials and cartridges within the pharmaceutical industry. This strategic alliance aims to streamline pharmaceutical manufacturing, improve operational efficiency, and … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Alliance for RTU, cartridges, Gerresheimer, partnership, Ready-to-Use Packaging Solutions, safety, SCHOTT Pharma, Stevanato Group, sustainability, vials
(IN BRIEF) Roche has announced positive results from its phase III REGENCY study, showing that its drug Gazyva®/Gazyvaro® (obinutuzumab) significantly outperformed standard therapy in treating active lupus nephritis. The study found that patients receiving Gazyva/Gazyvaro, in combination with standard therapies, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Dr. Brad H. Rovin, Gazyva, kidney disease patients, Levi Garraway, lupus nephritis, Roche, safety
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?